Kariya Pharmaceuticals
PrivateLast Round
Grant
Jul 1, 2025
Est. Valuation
$33.33M
Total Funding Raised
$4.63M
Company Overview
Kariya Pharmaceuticals operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Grant round in July 2025.
Kariya Pharmaceuticals is a biotechnology company that develops innovative disease modifying agents to treat neurodegenerative diseases such as Parkinson's and Alzheimer's Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kariya Pharmaceuticals Comparables
Compare Kariya Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| D&D Pharmatech | 79% | |
| Peptron Inc. | 78% | |
| T3D Therapeutics, Inc. | 77% |
For institutional investors. Book with your work email.
Kariya Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2025 | ||||
| Corporate Funding | Apr 16, 2024 | ||||
| Convertible Debt | Feb 1, 2019 |
For institutional investors. Book with your work email.
Kariya Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| BioInnovation Institute | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
$850K grant received from Innovation Fund Denmark.
- Nov 4, 2024
Grew 150% QoQ, from 2 to 5 employees.
For institutional investors. Book with your work email.
Kariya Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kariya Pharmaceuticals's valuation, stock price, and market status.
Is Kariya Pharmaceuticals a public or private company?
Kariya Pharmaceuticals is a private company.
What is the current stock price of Kariya Pharmaceuticals?
Kariya Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Kariya Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kariya Pharmaceuticals worth (valuation)?
Kariya Pharmaceuticals's valuation is estimated at $33.3M based on funding round data.
Can I buy Kariya Pharmaceuticals stock?
Kariya Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kariya Pharmaceuticals's last funding round?
Kariya Pharmaceuticals's most recent funding round was Grant on July 1, 2025.
Who are the main investors in Kariya Pharmaceuticals?
Key investors in Kariya Pharmaceuticals include BioInnovation Institute.
Will Kariya Pharmaceuticals IPO soon?
No public IPO plans have been announced for Kariya Pharmaceuticals.
How can I track Kariya Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Kariya Pharmaceuticals's shares on secondary markets.